Core Viewpoint - *ST Tianmao plans to voluntarily delist its A-shares from the Shenzhen Stock Exchange due to difficulties in disclosing its annual report and the first quarter report for 2025 [2][5]. Group 1: Delisting Process - On September 4, *ST Tianmao announced its intention to withdraw its A-shares from trading on the Shenzhen Stock Exchange through a shareholder resolution [2]. - The company had previously disclosed its plan for voluntary delisting on August 8, emphasizing the establishment of mechanisms to protect dissenting shareholders [4]. - The delisting was approved during the company's first extraordinary general meeting in 2025, and the application for delisting was submitted to the Shenzhen Stock Exchange [4]. Group 2: Financial and Regulatory Issues - *ST Tianmao's stock was placed under delisting risk warning on July 8, 2025, due to the failure to disclose the 2024 annual report and the first quarter report for 2025 within the legal timeframe [5]. - If the company fails to disclose more than half of the board members' guarantees for the 2024 annual report within two months of the delisting risk warning, the Shenzhen Stock Exchange will terminate the company's stock listing [5]. - The company is currently under investigation by the China Securities Regulatory Commission for failing to disclose periodic reports on time [5]. Group 3: Company Background - *ST Tianmao was publicly listed in 1996 and underwent a significant change in ownership in 2002 when Liu Yiqian became the actual controller after acquiring the company [5]. - The company transitioned from a pharmaceutical focus to the insurance industry, primarily operating through its subsidiaries Guohua Life and Huarui Insurance [5]. - As of August 13, 2025, *ST Tianmao's stock price was 1.58 yuan per share, with a total market capitalization of 7.7 billion yuan [6].

Core Viewpoint - *ST Tianmao has announced its decision to voluntarily withdraw its A-share listing from the Shenzhen Stock Exchange and will apply to transfer to the delisting section managed by the National Equities Exchange and Quotations after the termination of its listing [1][3]. Group 1: Company Actions - On August 8, *ST Tianmao first disclosed its intention to voluntarily delist, stating that it would protect the interests of investors by establishing mechanisms for dissenting shareholders and other shareholder protections [3]. - The termination of the listing was approved during the company's first extraordinary general meeting of shareholders in 2025, and the company submitted the necessary application materials to the Shenzhen Stock Exchange [3]. - *ST Tianmao has confirmed that it will maintain stable operations post-delisting and has no plans for major asset restructuring or specific timelines for re-listing after the voluntary delisting [3]. Group 2: Financial and Regulatory Issues - The company faced difficulties in disclosing its 2024 annual report and the first quarter report for 2025, leading to a delisting risk warning on July 8, 2025. If the company fails to disclose a majority of the 2024 annual report within two months of the warning, the Shenzhen Stock Exchange will terminate its listing [4]. - On May 6, *ST Tianmao received a notice from the China Securities Regulatory Commission regarding an investigation for failing to disclose periodic reports on time [4]. - As of August 13, 2025, *ST Tianmao's stock price was 1.58 yuan per share, with a total market capitalization of 7.7 billion yuan, and it had over 111,900 shareholders as of July 18, 2025 [5][6].

Core Viewpoint - *ST Tianmao plans to voluntarily delist its A-shares from the Shenzhen Stock Exchange due to difficulties in disclosing its annual report and will apply for transfer to the delisting board managed by the National Equities Exchange and Quotations after the delisting [2][4] Group 1: Delisting Process - On August 8, *ST Tianmao first announced its intention to voluntarily delist its A-shares from the Shenzhen Stock Exchange [4] - The delisting proposal was approved at the company's first extraordinary general meeting in 2025 on August 25, and the company submitted the delisting application to the Shenzhen Stock Exchange [4] - After delisting, *ST Tianmao aims to maintain stable operations and protect shareholders' legal rights, with no plans for major asset restructuring or specific timelines for re-listing [4] Group 2: Reporting Issues - *ST Tianmao failed to disclose its 2024 annual report and the first quarter report for 2025 within the legal timeframe, leading to a delisting risk warning on July 8, 2025 [4][5] - If the company does not disclose more than half of the board's assurance of the 2024 annual report within two months of the delisting risk warning, the Shenzhen Stock Exchange will decide to terminate the company's stock listing [4] Group 3: Company Background - *ST Tianmao was publicly listed in 1996 and underwent a significant change in ownership in 2002 when Liu Yiqian became the actual controller after acquiring the company [5] - The company transitioned from a pharmaceutical focus to the insurance industry, primarily operating through its subsidiaries, Guohua Life and Huarui Insurance [5] - As of August 13, the last trading day, *ST Tianmao's stock price was 1.58 yuan per share, with a total market capitalization of 7.7 billion yuan [5]

Core Viewpoint - *ST Tianmao plans to voluntarily delist from the Shenzhen Stock Exchange due to difficulties in disclosing its annual report, aiming to protect shareholder interests through a resolution at the shareholders' meeting [2][4]. Group 1: Delisting Process - On August 8, *ST Tianmao first announced its intention to voluntarily delist its A-shares from the Shenzhen Stock Exchange [4]. - The company received approval for the delisting at its 2025 first extraordinary shareholders' meeting held on August 25, and subsequently submitted the delisting application to the exchange [4]. - After delisting, *ST Tianmao intends to maintain stable operations and protect shareholder rights, with no current plans for major asset restructuring or a timeline for potential relisting [4]. Group 2: Financial Reporting Issues - *ST Tianmao was unable to disclose its 2024 annual report and the 2025 first-quarter report within the legal timeframe, leading to a delisting risk warning on July 8, 2025 [6]. - If the company fails to disclose a majority of its board's assurance of the report's authenticity within two months of the delisting risk warning, the Shenzhen Stock Exchange will decide to terminate its stock listing [6]. Group 3: Regulatory Actions - On May 6, *ST Tianmao received a notice from the China Securities Regulatory Commission regarding an investigation for failing to disclose periodic reports on time [7]. Group 4: Company Background - *ST Tianmao was publicly listed in 1996 and underwent a significant ownership change in 2002 when Liu Yiqian became the actual controller after acquiring the company [8]. - The company transitioned from a pharmaceutical focus to insurance, primarily operating through its subsidiaries, Guohua Life and Huarui Insurance [8]. - As of August 13, the company's stock price was 1.58 yuan per share, with a total market capitalization of 7.7 billion yuan, and it had over 110,000 shareholders as of July 18 [8][10].

Group 1 - Guoxin Technology successfully tested a new generation of automotive electronic BLDC motor drive control high-performance chip "CBC2100B," which is based on 130nm BCD process and aims to address the MCU chip shortage in China's automotive industry, especially in new energy vehicles [1] - The chip is applicable in automotive electronic fields such as water pumps, oil pumps, and air conditioning fans, as well as in industrial control for BLDC motor drives and electrified equipment [1] Group 2 - Hangzhou High-tech experienced a change in control with the resignation of multiple key executives, including the chairman, vice chairman, and general manager, which may lead to a temporary reduction in the board's member count below the minimum required [2] - The resigning executives will continue to perform their duties until new appointments are made to ensure the company's normal operations [2] Group 3 - Zhonghuan Hailu decided to terminate the planning of a change in control due to disagreements with the trading party regarding future development arrangements [4] - The stock and convertible bonds of the company will resume trading on September 5, 2025 [4] Group 4 - ST Tianmao plans to voluntarily withdraw its A-shares from trading on the Shenzhen Stock Exchange and apply for transfer to the National SME Share Transfer System after the termination of listing [5] - The decision has been approved by the company's first temporary shareholders' meeting in 2025 [5] Group 5 - Beijing Lier signed a strategic cooperation agreement with SenseTime and Xiwang to explore AI computing power collaboration and the development of industrial manufacturing and decision-making AI vertical models [6] - Hunan Baiyin adjusted its share repurchase price ceiling from 5 yuan to 7 yuan per share due to the stock price exceeding the original limit [6] Group 6 - Dongnan Network won the bid for the "Pujiang Street Five Villages Joint Development Project" with a bid amount of 1.686 billion yuan, accounting for 15% of the company's audited revenue for 2024 [8] - Wens Foodstuff reported sales of 3.2457 million pigs in August 2025, generating revenue of 4.825 billion yuan, with a year-on-year price change of 37.88% [8] - Jiangling Motors sold 30,003 vehicles in August 2025, representing a year-on-year increase of 8.92% [8] Group 7 - Hubei Yihua completed the construction of a 200,000 tons/year caustic soda energy-saving renovation project, which has been put into production [9] - Satellite Chemical announced routine maintenance for its polyethylene and ethylene oxide/ethylene glycol facilities, expected to last 45 days [9] Group 8 - Shida Shenghua plans to establish a subsidiary for a 53,000 tons/year calcium chloride project with an investment of 25 million yuan, aimed at enhancing its resource advantages in the new energy materials sector [11] - Roman Co. intends to acquire a 39.2308% stake in Wutong Technology for 196.154 million yuan, which will make Wutong a subsidiary of Roman [11] Group 9 - Shanghai Laishi's executives plan to increase their shareholdings in the company with a total investment of no less than 6 million yuan [13]

Group 1 - The State Council issued an opinion to promote high-quality development of the sports industry, aiming for a total scale exceeding 7 trillion yuan by 2030 [2] - The People's Bank of China will conduct a 1 trillion yuan reverse repurchase operation to maintain liquidity in the banking system [2] - The Ministry of Industry and Information Technology and the State Administration for Market Regulation released an action plan for the electronic information manufacturing industry, focusing on high-quality development in the photovoltaic sector [3] Group 2 - China Shipbuilding announced that its A-share stock will be delisted on September 5 [5] - Xiamen Electric Power confirmed no undisclosed significant matters [5] - Guoxin Technology successfully tested a new high-performance chip for automotive electronics [5] - Beijing Lier is exploring AI-related business through strategic cooperation with SenseTime and Xiwang [5] - Ji Feng Technology plans to establish a wholly-owned subsidiary for low-altitude industry investment and operation [5] - KBD plans to acquire 60% of KBD Intelligent Technology for 345 million yuan, entering the automotive intelligence sector [5] - Zhongwei Company launched six new semiconductor equipment products [5]

Core Viewpoint - Tianmao Industrial Group Co., Ltd. plans to voluntarily withdraw its A-share listing on the Shenzhen Stock Exchange and subsequently apply for transfer to the National Small and Medium Enterprises Share Transfer System for management in the delisting section [2][12]. Group 1: Company Overview - Company Name: Tianmao Industrial Group Co., Ltd. - Stock Listing Location: Shenzhen Stock Exchange - Stock Code: 000627 - Registered Capital: 494,062.92 million RMB - Main Business: Engaged in insurance business through subsidiaries Guohua Life and Huarui Insurance [4][11]. Group 2: Delisting Plan - The company intends to withdraw its A-share listing due to significant uncertainties arising from business restructuring, aiming to protect the interests of minority shareholders [12][16]. - The delisting proposal has been approved by more than two-thirds of the voting rights at the shareholders' meeting [17]. Group 3: Financial Advisor's Opinion - The financial advisor, CITIC Construction Investment Securities Co., Ltd., confirms that the delisting plan complies with relevant regulations and that the information disclosed meets the requirements of the Shenzhen Stock Exchange [16][17]. - The financial advisor has verified that the company’s announcement documents are accurate and complete, and the delisting process has been conducted independently without conflicts of interest [6][16]. Group 4: Shareholder Protection Mechanism - A cash option will be provided to dissenting shareholders, allowing them to receive cash compensation for their shares, excluding certain restricted shares [13][15]. - The cash option price is set at 1.60 RMB per share, with the registration date for eligible shareholders on September 2, 2025 [15].

Core Viewpoint - *ST Tianmao (000627) has announced its decision to voluntarily withdraw its A-shares from trading on the Shenzhen Stock Exchange and subsequently apply for transfer to the delisting segment managed by the National Equities Exchange and Quotations after the termination of its listing [1] Group 1 - The termination of listing has been approved by the company's first extraordinary general meeting of shareholders held on August 25, 2025 [1] - The termination of listing falls under the voluntary delisting circumstances as specified in Article 9.7.1 of the Shenzhen Stock Exchange Listing Rules [1] - The company has submitted the necessary application materials for voluntary delisting to the Shenzhen Stock Exchange [1]

Core Viewpoint - *ST Tianmao (000627) announced its decision to voluntarily withdraw its A-share listing on the Shenzhen Stock Exchange and apply for transfer to the National Equities Exchange and Quotations (NEEQ) after the delisting [1] Group 1 - The company has submitted the application materials for voluntary delisting to the Shenzhen Stock Exchange [1] - The termination of the company's stock listing is subject to approval from the Shenzhen Stock Exchange [1]

智通财经APP讯，*ST天茂(000627.SZ)发布公告，公司拟以股东会决议方式主动撤回A股股票在深圳证 券交易所(简称"深交所")的上市交易，并在股票终止上市后申请转入全国中小企业股份转让系统有限责 任公司代为管理的退市板块转让(简称"本次终止上市")。本次终止上市事项已于2025年8月25日经公司 2025年第一次临时股东会审议通过。基于上述，公司本次终止上市属于《深圳证券交易所股票上市规 则》(以下简称"《深交所股票上市规则》")9.7.1条第一款规定的主动终止上市情形。按照深交所的相关 规定，公司已向深交所提交主动终止上市申请材料。 ...